96136 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms; Five-membered rings having the nitrogen atoms in positions 1 and 3
Sub-classes:SMALL MOLECULE COMPOUNDS WITH PHOSPHORYLATED ARYL STRUCTURES AND USE THEREOF
#2NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF
#3METHOD FOR PREPARING PHOSPHORUS-CONTAINING LIGAND
#4TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS
#5HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
#6QUINOLINE cGAS ANTAGONIST COMPOUNDS
#7Synthesis Process of X-IPM, Stable Crystal Form and Application Thereof
#8POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
#9TREATMENT AND DIAGNOSIS OF MELANOMA
#105-BENZYLIMIDAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF
#11Tropomyosin-related kinase (trk) inhibitors
#12COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
#13Nonaqueous Electrolytic Solution, Nonaqueous Electrolytic Solution Battery, and Compound
#14Quinoline cGAS antagonist compounds
#15BUTYL-BRIDGED DIPHOSPHINE LIGANDS FOR ALKOXYCARBONYLATION
#16CLEAVABLE AGENTS
#17IONIC LIQUID, ELECTROLYTE FOR SECONDARY BATTERY INCLUDING IONIC LIQUID, AND SECONDARY BATTERY INCLUDING ELECTROLYTE
#18Hydantoin containing deoxyuridine triphosphatase inhibitors
#19ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION
#20Quinoline cGAS antagonist compounds
#21Tropomyosin-related kinase (Trk) inhibitors
#22Hydantoin containing deoxyuridine triphosphatase inhibitors
#233,5-BIS(PHENYL)-1H-HETEROARYL DERIVATIVES AS MEDICAMENTS
#24INHIBITORS OF THE ENZYME ENOLASE FOR PRECISION ONCOLOGY
#25Method for the diagnosis, prognosis and treatment of breast cancer metastasis
#26Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells
#27BUTYL-BRIDGED DIPHOSPHINE LIGANDS FOR ALKOXYCARBONYLATION
#28Treatment and diagnosis of melanoma
#29Tropomyosin-related kinase (TRK) inhibitors
#30Luminescent compound
#31Skeletal removal of bisphosphonates
#32Dyes for Analysis of Soluble Protein Aggregates or Misfolded Protein Oligomers
#33Hydantoin containing deoxyuridine triphosphatase inhibitors
#34Treatment and diagnosis of melanoma
#35Biaryl ligands, methods of making biarlyl ligands, and methods of use thereof
#36Cleavable agents
#37Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells
#38Inhibitors of creatine transport and uses thereof
#39Compositions for oral administration of zoledronic acid or related compounds for treating disease
#40NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#41BIOCIDAL COATINGS AND METHODS FOR MAKING SAME
#42NERIDRONIC ACID AND OTHER BISPHOSPHONATES FOR TREATING COMPLEX REGIONAL PAIN SYNDROME AND OTHER DISEASES
#43Skeletal removal of bisphosphonates
#44TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS
#45Method for the diagnosis, prognosis and treatment of breast cancer metastasis
#46Crystalline forms
#47TH-302 solid forms and methods related thereto
#48NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#49DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
#50Crystalline forms
#51Probes for 18F Positron Emission Tomography Imaging
#52Predictive biomarker for hypoxia-activated prodrug therapy
#53Crystallization method and bioavailability
#54Biaryl ligands, methods of making biaryl ligands, and methods of use thereof
#55Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#56Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#57Compositions for oral administration of zoledronic acid or related compounds for treating disease
#58Hydantoin containing deoxyuridine triphosphatase inhibitors
#59Hydantoin containing deoxyuridine triphosphatase inhibitors
#60Treatment and diagnosis of melanoma
#61Fluorine-containing bisphosphonic acid derivative and use thereof
#62Amino phosphazene bases as n-dopants in organic electronics
#63Methods for the safe administration of imidazole or imidazolium compounds
#64TH-302 solid forms and methods related thereto
#65Inhibitors of creatine transport and uses thereof
#66Ferrocene-based compounds and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds
#67Monophosphine compounds and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds
#68Formylpyrrole-based heterocycles for nucleic acid attachment to supports
#69THERAPEUTIC USES OF BISPHOSPHONATES
#70Method for the synthesis of aminoalkylenephosphonic acid
#71BIOCIDAL COMPOUNDS AND METHODS FOR USING SAME
#72Formylpyrrole-based heterocycles for nucleic acid attachment to supports
#73Use of an adrenal hormone-modifying agent
#74Crystallization method and bioavailability
#75Crystallization method and bioavailability
#76Functionalized fluoroalkyl fluorophosphate salts
#77NOVEL DXR INHIBITORS FOR ANTIMICROBIAL THERAPY
#78Crystallization method and bioavailability
#79Use of an adrenal hormone-modifying agent
#80CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#81ORGANIC ELECTROLUMINESCENT DEVICE
#82Endosseous implant
#83Substituted propane phosphinic acid derivatives
#84Phosphine Borane Compounds Comprising Imidazol Groups And Method For Producing Phosphine Borane Compounds Comprising Imidazol Groups
#85Oral forms of a phosphonic acid derivative
#86Bisphosphonates as Inhibitors of Acid Sphingomyelinase
#87TETRA-SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR USE AS MDM2 AND/OR MDM4 MODULATORS
#88Compounds as receptor modulators with therapeutic utility
#89Process for the preparation of [1-hydroxy-2-(1-imidazol-1-yl)- ethylidene]bisphosphonic acid
#90Polymer nanoparticles
#91Components for producing amphoteric liposomes
#92FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF
#93Non-Signal Imidazole Reagents for Mass Spectrometry Analysis of Phosphomonoesters
#94Electronically tuned ligands for asymmetric hydrogenation
#95PHENYLALKYL-IMIDAZOLE-BISPHOSPHONATE COMPOUNDS
#96Phosphoramidate alkylator prodrugs
#97Chemoselective ligation
#98C2-C5-Alkyl-Imidazole-Bisphosphonates
#99BISPHOSPHONATE-PROSTATIC ACID PHOSPHATASE INHIBITOR CONJUGATES TO TREAT PROSTATE CANCER BONE METASTASIS
#100Crystallization method and bioavailability
#101NOVEL LIPOPHILIC COMPOSITIONS AND USES THEREOF
#102IMIDAZOLE GROUP-CONTAINING PHOSPHORUS COMPOUNDS
#103Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
#104N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE
#105Endosseous implant
#106Functionalized ionic liquids, and methods of use thereof
#107Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it
#108Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it
#109α-Amino acid phosphonic acid compounds, method of preparation of use thereof
#110Functionalized Ionic Liquids, and Methods of Use Thereof
#111Creatine phosphate analog prodrugs, compositions and uses thereof
#112Phosphoramidate alkylator prodrugs
#113Process for Making Zoledronic Acid
#114Certain Chemical Entities, Compositions, and Methods
#115CRYSTALLINE FORMS OF ZOLEDRONIC ACID
#116Electronically tuned ligands for asymmetric hydrogenation
#117Method for prophylactic treatment of alzheimer's disease using inhibitors of glutaminyl cyclase and glutamate cyclases
#118Process for the Preparation of Biphosphonic Acids and Salts Thereof
#119AGONISTS OF THE SPHINGOSINE-1 PHOSPHATE RECEPTOR
#120Process for producing biphosphonic acids and forms thereof
#121Imidazopyridinyl benzamide mitotic kinesin inhibitors
#122Imidazopyridinyl benzamide mitotic kinesin inhibitors
#123Reactive pyrophosphoric and bisphosphonic acid derivatives and methods of their use
#124CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#125Electrostatic-image-developing toner, method of producing the same, electrostatic image developer, image forming method and image forming apparatus
#126Non-signal imidazole reagents for mass spectrometry analysis of phosphomonoesters
#127Novel Process For Making Bisphosphonic Acids Using Diluents Other Than Halogenated Hydrocarbons
#128N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
#129C-C-alkyl-imidazole-bisphosphonates
#130PROCESS FOR MANUFACTURING BISPHOSPHONIC ACIDS
#131DEUTERIUM-ENRICHED ZOLEDRONIC ACID
#132Pesticidal heterocycles
#133Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
#134Lysophosphatidic acid receptor selective antagonists
#135Synthesis of drug conjugates via reaction with epoxide-containing linkers
#136Cycloolefin phosphine ligands and their use in catalysis
#137N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
#138Agent for preventing or treating neuropathy
#139Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease
#140Crystalline Trihydrate of Zoledronic Acid
#141Certain chemical entities, compositions, and methods
#142Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
#143Chemoselective ligation
#144Alpha-HYDROXY, alpha-SUBSTITUTED METHYLENEBISPHOSPHONATES AND PHOSPHONOACETATES
#145Inhibitors of glutaminyl cyclase
#146Functionalized ionic liquids, and methods of use thereof
#147CRYSTALLINE FORM OF THE ZOLEDRONIC ACID, A PROCESS TO OBTAIN IT AND THE PHARMACEUTICAL COMPOSITION COMPRISING IT
#1482-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases
#149Methods and compositions for modulating sphingosine -1- phosphate (S1P) receptor activity
#150Creatine phosphate analog prodrugs, compositions and uses thereof
#151Inhibitors of β-lactamase
#152Bisphosphonate compounds and methods
#153PROCESS FOR PREPARING FOSPHENYTOIN
#154Method for Producing Sodium Fosphenytoin
#155Compounds active in sphingosine 1-phosphate signaling
#156Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
#157Method and compositions for identifying anti-hiv therapeutic compounds
#158Transition-metal complexes with tridentate, nitrogen-containing ligands
#159Seven-membered ring nucleosides
#160Bisphosphines as bidentate ligands
#161Process for the preparation of biphosphonic acids
#162N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
#163Imidazoyl-benzamide anti-cancer agents
#164Process for preparing bisphosphonic acids
#165Bisphosphines as bidentate ligands
#166Nitrogen-containing monodentate phosphines and their use in catalysis
#167Process for the preparation of alkyl- and aryl-diphosphonic acids and salts thereof
#168Novel chelated bisphosphonates for use as pharmaceutical agents
#169Orally available sphingosine 1-phosphate receptor agonists and antagonists
#170Imidazole compounds that modulate HSP90 activity
#171Antiresorptive mutual salt of raloxifene and bisphosphonic acid
#172Process for the preparation of bisphosphonic acid
#173Substituted propane phosphinic acid derivatives
#174Chemoselective ligation
#175Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases
#176Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
#177Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
#178Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
#179Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
#180Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
#181Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
#182Phospinite-imidazolines and metal complexes thereof
#183Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
#184Process for preparation of bisphosphonic acid compounds
#185Chemoselective ligation
#186Fuel cell membrane containing zirconium phosphate
#187Process for the preparation of biphosphonic derivatives
#188N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
#189Ligands for asymmetric reactions
#190Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
#191Lipophilic compounds and uses thereof
#192Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
#193Novel process for making bisphosphonic acids using diluents other than halogenated hydrocarbons
#194Non nucleoside reverse transcriptase inhibitors
#1952-Hydroxymethylcyclopropylidenemethylpurines and - pyrimidines as antiviral agents
#196Method and compositions for identifying anti-hiv therapeutic compounds
#197Phosphoramide derivatives
#198Cidofovir peptide conjugates as prodrugs
#199Novel inhibitors of beta-lactamase
#200Imidazopyridinyl-benzamide anti-cancer agents
#201Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
#202Aromatic compounds containing nitrogen and p- functionalized amines, the production thereof and their use in catalytic reactions
#203Noncardiotoxic pharmaceutical compounds
#204Agent for preventing or treating neuropathy
#205Preparation of biphosphonic acids and salts thereof
#206Process for the preparation of sodium fosphenytoin
#207Method and compositions for identifying anti-HIV therapeutic compounds
#208Compounds active in spinigosine 1-phosphate signaling
#209Bisphosphines as bidentate ligands
#210Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
#211Non nucleoside reverse transcriptase inhibitors
#212Components for producing amphoteric liposomes
#213Chemoselective ligation
#214Pesticidal heterocycles
#215Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels
#216Oxazoline ligands for asymmetric catalysis
#217Novel lysophosphatidic acid receptor agonists and antagonists
#218Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease
#219Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
#220Production of imidazole derivatives and novel intermediates of the derivatives
#221Inhibitors of β-lactamase
#2222-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents
#223Substituted imidazolium compounds for treating disease